Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
作者信息
Madsen S
出版信息
Acta Med Scand Suppl. 1980;638:3-120.
PMID:6929650
Abstract
摘要
相似文献
1
Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
Acta Med Scand Suppl. 1980;638:3-120.
2
Phosphate and 1alpha-hydroxyvitamin D3 therapy in haemodialysis patients.
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:91s-99s. doi: 10.1111/j.1365-2265.1977.tb03368.x.
3
Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:73s-81s. doi: 10.1111/j.1365-2265.1977.tb03365.x.
4
Minor influence of parathyroid hormone on fractional tubular reabsorption of phosphate in chronic renal failure.甲状旁腺激素对慢性肾衰竭时肾小管磷重吸收分数的影响较小。
Adv Exp Med Biol. 1977;81:131-9. doi: 10.1007/978-1-4613-4217-5_15.
5
1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
Calcif Tissue Res. 1976 Aug;21 Suppl:226-35.
6
The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.磷酸盐及其他因素在肾性骨营养不良发病机制中的作用。
Adv Exp Med Biol. 1977;81:467-75. doi: 10.1007/978-1-4613-4217-5_47.
7
Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.
Proc Eur Dial Transplant Assoc. 1981;18:567-72.
8
The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients.
Adv Exp Med Biol. 1977;81:559-69. doi: 10.1007/978-1-4613-4217-5_54.
9
Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.1,25(OH)₂D₃在肾性骨营养不良管理中的应用现状
Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154.
10
How important is phosphate in the pathogenesis of renal osteodystrophy?
Arch Intern Med. 1978 May 15;138 Spec No:848-52.
Zotero 插件